Literature DB >> 2478590

Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils.

P A Ory1, M R Clark, E E Kwoh, S B Clarkson, I M Goldstein.   

Abstract

Two polymorphic forms of Fc receptor III (FcR III) are expressed on human neutrophils. These differ with respect to their apparent molecular masses after digestion with N-glycanase, and with respect to their reactivity with MAb Gran 11 and alloantisera which recognize determinants (NA1 and NA2) of the biallelic neutrophil antigen (NA) system. To determine the molecular basis for this polymorphism we isolated RNA from neutrophils of NA1NA1 and NA2NA2 homozygotes and synthesized corresponding cDNAs. cDNAs encoding FcR III were then amplified using the polymerase chain reaction, cloned, and sequenced. The cDNA that encodes FcR III on NA1NA1 neutrophils differed from the cDNA that encodes FcR III on NA2NA2 neutrophils at five nucleotides, predicting four amino acid substitutions. As a result, NA1 FcR III has only four potential N-linked glycosylation sites as compared with six in NA2 FcR III. The amino acid substitutions and differences in the number of potential N-linked glycosylation sites probably account for the different forms of neutrophil FcR III observed after digestion with N-glycanase and for the antigenic heterogeneity of this receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478590      PMCID: PMC304039          DOI: 10.1172/JCI114350

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  Function and heterogeneity of human Fc receptors for immunoglobulin G.

Authors:  J C Unkeless
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Biochemical characterization of an Fc gamma receptor purified from human neutrophils.

Authors:  H B Fleit; M Kuhnle
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

4.  The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein.

Authors:  D Simmons; B Seed
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

5.  The PI-linked receptor FcRIII is released on stimulation of neutrophils.

Authors:  T W Huizinga; C E van der Schoot; C Jost; R Klaassen; M Kleijer; A E von dem Borne; D Roos; P A Tetteroo
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

6.  The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria.

Authors:  P Selvaraj; W F Rosse; R Silber; T A Springer
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

7.  Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction.

Authors:  P J Newman; J Gorski; G C White; S Gidwitz; C J Cretney; R H Aster
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

8.  Production of single-stranded plasmid DNA.

Authors:  J Vieira; J Messing
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

9.  Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.

Authors:  L L Lanier; J J Ruitenberg; J H Phillips
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

10.  Selective synthesis of mRNA and proteins by human peripheral blood neutrophils.

Authors:  R M Jack; D T Fearon
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

View more
  35 in total

1.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function.

Authors:  J E Salmon; J C Edberg; N L Brogle; R P Kimberly
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

3.  Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism.

Authors:  A F Reilly; C F Norris; S Surrey; F J Bruchak; E F Rappaport; E Schwartz; S E McKenzie
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 4.  Molecular nature of antigens implicated in immune neutropenias.

Authors:  Juergen Bux
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities.

Authors:  J E Salmon; J C Edberg; R P Kimberly
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

6.  Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.

Authors:  L A Sanders; R G Feldman; M M Voorhorst-Ogink; M de Haas; G T Rijkers; P J Capel; B J Zegers; J G van de Winkel
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils.

Authors:  Yue Wang; Jianming Wu; Robert Newton; Nooshin S Bahaie; Chunmei Long; Bruce Walcheck
Journal:  Biochim Biophys Acta       Date:  2012-12-08

8.  An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus.

Authors:  Edward J Hollox; Jan-Christoph Detering; Tushna Dehnugara
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia.

Authors:  Marcin Wojciech Wlodarski; Zachary Nearman; Ying Jiang; Alan Lichtin; Jaroslaw Pawel Maciejewski
Journal:  Exp Hematol       Date:  2008-03       Impact factor: 3.084

10.  Functions of Antibodies.

Authors:  Donald N Forthal
Journal:  Microbiol Spectr       Date:  2014-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.